What is John Mertzlufft's NPI number?

John Mertzlufft's National Provider Identifier (NPI) is 1992985774, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is John Mertzlufft's specialty?

John Mertzlufft is listed in the NPPES registry with a primary specialty of Optometrist (Eye and Vision Services Providers).

Where is John Mertzlufft located?

John Mertzlufft's practice location on file with NPPES is 12311 W Linebaugh Ave, Tampa, FL 33626-2651.

What is John Mertzlufft's phone number?

The practice phone number listed in the NPPES registry for John Mertzlufft is (813) 814-2020.

Does John Mertzlufft accept Medicare?

John Mertzlufft is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is John Mertzlufft's NPI active?

Yes — John Mertzlufft's NPI (1992985774) is active in the NPPES registry as of the last update on 2021-02-05.

IndividualActiveAccepts Medicare

John Mertzlufft, O.D.

NPI 1992985774 · Optometrist · Tampa, FL

John Mertzlufft, O.D. is a Optometrist provider in Tampa, FL (NPI 1992985774).

Provider details

NPI number: 1992985774
Entity type: Individual
Primary specialty: OptometristEye and Vision Services Providers
Credential: O.D.
Sex: Male
Sole proprietor: Yes
License: 2610 (FL)

Practice location

12311 W Linebaugh Ave

Tampa, FL 33626-2651

Phone: (813) 814-2020

Fax: (813) 814-9944

Street-level locationGet directions

More FL providers

Mailing address

12311 W Linebaugh Ave

Tampa, FL 33626-2651

Specialties & taxonomies

OptometristPrimary152W00000XLicense 2610 (FL)
Eye and Vision Services Providers

Additional practice locations (1)

12037 Whitmarsh Ln
Suite 101
Tampa, FL 33626-1737
Phone: (813) 814-2020
Fax: (813) 814-9944

Enrolled with Medicare as Practitioner - Optometry · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Established profile(74/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
19 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
2 documented practice locations
Medicare service volume (vs. specialty peers)25% of score
208 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Complete Exam of Visual System92014	115	$120
Established Patient Office Or Other Outpatient Visit With Straightforward Medical Decision Making, If Using Time, 10 Minutes Or More99212	31	$55
Photography of the Retina92250	24	$35
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	14	$88
New Patient Complete Exam of Visual System92004	13	$141
Exam of Visual Field With Extended Testing92083	11	$60

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 3 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Latanoprost	49	13
Timolol Maleate	25	—
Dorzolamide Hcl/Timolol Maleatbrand: Dorzolamide-Timolol	13	—

Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do not include cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means no Part D record, never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$671 across 11 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2007-11-08
Last updated: 2021-02-05
Certified: 2021-02-05

Frequently asked questions

What is John Mertzlufft's NPI number?: John Mertzlufft's National Provider Identifier (NPI) is 1992985774, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is John Mertzlufft's specialty?: John Mertzlufft is listed in the NPPES registry with a primary specialty of Optometrist (Eye and Vision Services Providers).
Where is John Mertzlufft located?: John Mertzlufft's practice location on file with NPPES is 12311 W Linebaugh Ave, Tampa, FL 33626-2651.
What is John Mertzlufft's phone number?: The practice phone number listed in the NPPES registry for John Mertzlufft is (813) 814-2020.
Does John Mertzlufft accept Medicare?: John Mertzlufft is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is John Mertzlufft's NPI active?: Yes — John Mertzlufft's NPI (1992985774) is active in the NPPES registry as of the last update on 2021-02-05.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Complete Exam of Visual System92014	115	$120
Established Patient Office Or Other Outpatient Visit With Straightforward Medical Decision Making, If Using Time, 10 Minutes Or More99212	31	$55
Photography of the Retina92250	24	$35
Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213	14	$88
New Patient Complete Exam of Visual System92004	13	$141
Exam of Visual Field With Extended Testing92083	11	$60

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 3 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Latanoprost	49	13
Timolol Maleate	25	—
Dorzolamide Hcl/Timolol Maleatbrand: Dorzolamide-Timolol	13	—

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$671 across 11 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Additional practice locations (1)

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Additional practice locations (1)

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments